- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03799146
Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Older Adults
A Randomized Controlled Trial to Identify the Effect and the Working Mechanisms of MyPlan 2.0, a Self-regulation-based e- and mHealth Intervention Targeting Physical Activity and Sedentary Behaviour, in Older Adults
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The aim of this study is to investigate whether and how 'MyPlan 2.0' helps older adults to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group. Both groups will be tested during three testing waves: pretest, posttest and follow-up test. Only the intervention group will be given acces to 'MyPlan 2.0'.
'MyPlan 2.0' consists of a website and mobile application targeting physical activity and sedentary behaviour. The intervention has a duration of five weeks.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Ghent, Belgien, 9000
- Department of Movement and Sports Sciences
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Have access to internet
- Being computer literate
Exclusion Criteria:
- non Dutch speaking
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Insatsgrupp
Deltagarna kommer att få e- och mHealth-interventionen "MyPlan 2.0".
|
MyPlan 2.0 består av fem sessioner.
Under dessa fem sessioner används följande beteendeförändringstekniker för att motivera användare att vara mer fysiskt aktiva eller att sitta mindre: utforska riskuppfattningar och upplevda fördelar, utforska socialt stöd, ge feedback, handlingsplanering, copingplanering och övervakning.
|
|
Experimentell: Waiting List control group
Participants will not receive the e- and mHealth intervention 'MyPlan 2.0', but will be given access to the intervention after all testing phases.
|
Waiting List control group
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Förändring i objektiv total, lätt och måttlig till kraftig fysisk aktivitet (PA)
Tidsram: Förtest, eftertest (6 veckor) och uppföljning (6 månader)
|
Förändring i mängden total, lätt och måttlig till kraftig fysisk aktivitet, mätt med accelerometrar
|
Förtest, eftertest (6 veckor) och uppföljning (6 månader)
|
|
Förändring i objektivt stillasittande beteende
Tidsram: Förtest, eftertest (6 veckor) och uppföljning (6 månader)
|
Förändring i mängden total sitttid, mätt med accelerometrar
|
Förtest, eftertest (6 veckor) och uppföljning (6 månader)
|
|
Change in self-reported total, moderate and moderate-to-vigorous physical activity (PA) as well as total work-related, transport-related, household-related and leisure time PA.
Tidsram: Pretest, posttest (6 weeks) and follow-up (6 months)
|
Change in amount of total, light and moderate-to-vigorous PA well as total work-related, transport-related, household-related and leisure time PA will be measured via the International Physical Activity Questionnaire (IPAQ).
The IPAQ measures physical activity in four domains: work, transport, household and leisure time.
Higher scores indicate higher levels of physical activity.
For each scale the minimum value is 0. We will use the method described by Dubuy et al. (2013) to truncate the data.
|
Pretest, posttest (6 weeks) and follow-up (6 months)
|
|
Change in self-reported sedentary behaviour
Tidsram: Pretest, posttest (6 weeks) and follow-up (6 months)
|
Change in amount of total sitting time, measured via the LASA sedentary behaviour self-report questionnaire.
The total score is calculated by summing all 10 items.The minimum value is 0 and the maximum value is 24 hours.
However, data will be truncated at 16 hours.
|
Pretest, posttest (6 weeks) and follow-up (6 months)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in self-efficacy
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)
|
Change in amount of self-efficacy to change behaviour, measured via 5 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the five items will be considered the final score.
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)
|
|
Change in outcome expectancies
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Outcome expectancies regarding the behaviour change, measured via 5 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the five items will be considered the final score.
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
|
Change in risk perception
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Risk perception about the behaviour, measured via 4 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the four items will be considered the final score
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
|
Change in intention
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Amount of intention to change the behaviour, measured via 3 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the three items will be considered the final score.
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
|
Change in action planning
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Amount of action planning for behaviour change, measured via 3 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the three items will be considered the final score.
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
|
Change in coping planning
Tidsram: Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Amount of coping planning for behaviour change, measured via 3 validated items (questionnaire).
These items were created by the involved research groups.
For each item, the scale ranges from 1 to 10.
The average score on the three items will be considered the final score.
|
Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Ilse De Bourdeaudhuij, University Ghent
- Huvudutredare: Geert Crombez, University Ghent
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MyPlan2.0_older_adults_50
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .